Point of Care Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Medical Device Report Format : PDF Report Code: ZMR-6004 Status : Upcoming

Description

Global Point of Care Testing Market: Overview

Point of care (POC) testing devices are primarily used for diagnosis of disease for early detection and monitoring along with its effective treatment and management. These products are proliferating with a smart solution and embedded vision technology like the introduction of networking technologies, sample multiplexing, and miniaturization of devices.

Global Point of Care Testing Market: Growth Factors

One of the major factors driving the global point of care testing market is the growing prevalence of targeted and infectious diseases. Moreover, the outbreak of coronavirus has propelled the growth of POC testing vigorously. The increasing demand for home health care is further contributing vigorously to the growth of the global point of care testing market. The surging trend of the decentralization in the healthcare sector particularly, in patient care is creating many lucrative growth opportunities in the global point of care testing market. The functioning areas of POC testing are proliferating with digital technologies like smartphone-oriented solutions and thus propelling the growth of the global point of care testing market. Increasing research and developments in POC testing technologies to improve the process and innovation of more advanced technology is further fueling the growth of the market globally. The increasing number of pathologies all across the globe is expediting the growth of the global point of care testing market.

Global Point of Care Testing Market: Segmentation

The global point of care testing market can be segmented into end-use, product, technology, prescription, application, and region.

By end-use, the market can be segmented into clinics, laboratories, assisted living healthcare facilities, homes, and hospitals. The clinic segment accounts for the largest share in the global point of care testing market.

By product, the market can be segmented into urinalysis, drug abuse testing, ambulatory chemistry, blood gas/electrolytes, cancer marker, lipid testing, feces, decentralized clinical chemistry, primary care systems, hematology, thyroid-stimulating hormone, cardiac markers, infectious diseases, fertility, coagulation, Hb1Ac testing, and glucose testing. The infectious diseases segment holds hegemony over others.

By technology, the market can be segmented into biosensors, solid phase, flow-through, agglutination assays, immunoassays, molecular diagnostics, microfluidics, dipsticks, and lateral flow assays.

By prescription, the market can be segmented into prescription testing and OTC testing.

By application, the market can be segmented into cancer biomarker testing, pregnancy testing, blood glucose testing, drug-of-abuse (DoA) testing, nephrology testing, infectious disease testing, cardiometabolic testing, and others. The cardiometabolic testing segment holds the largest share in the global point of care testing market.

Global Point of Care Testing Market: Regional analysis

North America accounts for the largest share in the global point of care testing market owing to the rising number of cases of infectious diseases along with the growing applications of POC tests for early diagnosis of diseases. Moreover, the growing investment by the private funding organizations and government for the development and advancement of point of care diagnostic tests is likely to propel the growth of the regional market significantly during the forecast period.

Asia Pacific is anticipated to witness huge growth owing to the rapid development of healthcare infrastructure. The increasing prevalence of targeted and chronic diseases like cancer and diabetes is expected to boost the growth of the regional market.

Global Point of Care Testing Market: Competitive Players

Some of the significant players in the global point of care testing market are Spectral Medical, Inc., Nipro Corp., Orasure Technologies, Inc., Sekisui Diagnostics, Trinity Biotech, Quidel Corp., Trividia Health, Inc., Nova Biomedical, Instrumentation Laboratory, Zoetis, Inc., Siemens Healthcare AG, Abbott Laboratories, Biomerieux SA, Becton Dickinson (BD), Danaher Corp., Qiagen, F. Hoffmann-La Roche Ltd., Sysmex Corporation, Siemens Healthineers, F. Hoffmann-La Roche Ltd, OraSure Technologies Inc., Meridian Bioscience Inc, Medtronic, LifeScan IP Holdings, LLC, Dragerwerk Ag & Co., Dexcom Inc, Danaher Corporation, Bio-Rad Laboratories, BioMerieux SA, Biological Laboratories, Dickinson and Company, Becton, ACON Laboratories, Accubiotech Co. Ltd, Abbott, Abaxis, Inc, Alfa Scientific Designs, Inc., Binx Health, Inc., Biomerica, Inc., Acrongenomics Inc., ACON Laboratories, Inc., Alpha Scientific Electronics, and Johnson & Johnson Services, Inc.

Global Point of Care Testing Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

One of the major factors driving the global point of care testing market is the growing prevalence of targeted and infectious diseases. Moreover, the outbreak of coronavirus has propelled the growth of POC testing vigorously. The increasing demand for home health care is further contributing vigorously to the growth of the global point of care testing market. The surging trend of the decentralization in the healthcare sector particularly, in patient care is creating many lucrative growth opportunities in the global point of care testing market.

Some of the significant players in the global point of care testing market are Spectral Medical, Inc., Nipro Corp., Orasure Technologies, Inc., Sekisui Diagnostics, Trinity Biotech, Quidel Corp., Trividia Health, Inc., Nova Biomedical, Instrumentation Laboratory, Zoetis, Inc., Siemens Healthcare AG, Abbott Laboratories, Biomerieux SA, Becton Dickinson (BD), Danaher Corp., Qiagen, and F. Hoffmann-La Roche Ltd.

North America accounts for the largest share in the global point of care testing market owing to the rising number of cases of infectious diseases along with the growing applications of POC tests for early diagnosis of diseases.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com